Microscopy‐based assay for semi‐quantitative detection of SARS‐CoV‐2 specific antibodies in human sera
Authors:
Open Access
- 30 December 2020
- Vol. 43 (3) , e2000257
Abstract
Emergence of the novel pathogenic coronavirus SARS‐CoV‐2 and its rapid pandemic spread presents challenges that demand immediate attention. Here, we describe the development of a semi‐quantitative high‐content microscopy‐based assay for detection of three major classes (IgG, IgA, and IgM) of SARS‐CoV‐2 specific antibodies in human samples. The possibility to detect antibodies against the entire viral proteome together with a robust semi‐automated image analysis workflow resulted in specific, sensitive and unbiased assay that complements the portfolio of SARS‐CoV‐2 serological assays. Sensitive, specific and quantitative serological assays are urgently needed for a better understanding of humoral immune response against the virus as a basis for developing public health strategies to control viral spread. The procedure described here has been used for clinical studies and provides a general framework for the application of quantitative high‐throughput microscopy to rapidly develop serological assays for emerging virus infections.Keywords
All Related Versions
Funding Information
- Deutsche Forschungsgemeinschaft (240245660, 41607209)
This publication has 46 references indexed in Scilit:
- Fiji: an open-source platform for biological-image analysisNature Methods, 2012
- A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan ShieldScience, 2011
- The beautiful cell: high-content screening in drug discoveryAnalytical and Bioanalytical Chemistry, 2010
- The Pascal Visual Object Classes (VOC) ChallengeInternational Journal of Computer Vision, 2009
- Development of a Nucleocapsid-Based Human Coronavirus Immunoassay and Estimates of Individuals Exposed to Coronavirus in a U.S. Metropolitan PopulationClinical and Vaccine Immunology, 2008
- High-throughput fluorescence microscopy for systems biologyNature Reviews Molecular Cell Biology, 2006
- Immunofluorescence Assay for Detection of the Nucleocapsid Antigen of the Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus in Cells Derived from Throat Wash Samples of Patients with SARSJournal of Clinical Microbiology, 2005
- Antibody responses to individual proteins of SARS coronavirus and their neutralization activitiesMicrobes and Infection, 2005
- Evaluation of a safe and sensitive Spike protein-based immunofluorescence assay for the detection of antibody responses to SARS-CoVJournal of Immunological Methods, 2005
- Immunofluorescence Assay for Serologic Diagnosis of SARSEmerging Infectious Diseases, 2004